Skip Navigation


European Heart Journal Advance Access originally published online on November 2, 2005
European Heart Journal 2006 27(1):3-4; doi:10.1093/eurheartj/ehi627
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
27/1/3    most recent
ehi627v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Reyes, E.
Right arrow Articles by Underwood, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reyes, E.
Right arrow Articles by Underwood, S. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2005. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Myocardial perfusion scintigraphy: an important step between clinical assessment and coronary angiography in patients with stable chest pain

Eliana Reyes and Stephen Richard Underwood*

Imperial College, National Heart and Lung Institute, London, UK and Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK

* Corresponding author. E-mail address: r.underwood@imperial.ac.uk

This editorial refers to ‘Potential impact of myocardial perfusion scintigraphy as gatekeeper for invasive examination and treatment in patients with stable angina pectoris: observational study without post-test referral bias’{dagger} by P.F. Høilund-Carlsen et al., on page 29

The first 10% of the full text of this article appears below.

Myocardial perfusion scintigraphy (MPS) is an effective and cost-effective technique in patients presenting with stable chest pain. It provides a reliable assessment of coronary obstruction leading to inducible perfusion abnormalities and of the prognosis of disease. It can therefore be used both for diagnosis and for triage of patients between initial medical therapy and invasive investigation with a view to revascularization. It is recommended as the first-line diagnostic procedure when exercise electrocardiography is difficult or inconclusive, such as when the resting ECG is abnormal, when maximal dynamic exercise is unlikely to be achieved, and in women.1 Although comparison between a test of coronary function and coronary anatomy is fraught with difficulties, the sensitivity of MPS for detecting angiographic stenosis is 85–90% and the normal MPS rate in a low likelihood population (normalcy) is 90–95%, depending upon the population . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Potential impact of myocardial perfusion scintigraphy as gatekeeper for invasive examination and treatment in patients with stable angina pectoris: observational study without post-test referral bias
Poul F. Høilund-Carlsen, Allan Johansen, Henrik Wulff Christensen, Werner Vach, Mette Møldrup, Peter Bartram, Annegrete Veje, Torben Haghfelt, and for the Myocardial Ischemia Logistics Evaluation Study (MILES) Group
EHJ 2006 27: 29-34. [Abstract] [Full Text]